Combining Radiomics and Autoencoders to Distinguish Benign and Malignant Breast Tumors on US Images

Zuzanna Anna Magnuska1, Rijo Roy1, Moritz Palmowski1

  • 1From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Radiology
|September 10, 2024
PubMed
Summary

This study developed a precise, real-time capable ultrasound (US) breast tumor categorization system. Combining radiomics and autoencoder features, the AI model achieved high accuracy, matching human readers for improved breast cancer diagnosis.